MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors.
Dong-Hyun Kim, Jeane Chen, Reed A Omary, Andrew C Larson
Index: Theranostics 5(5) , 477-88, (2015)
Full Text: HTML
Abstract
Magnetic resonance imaging (MRI)-visible amonafide-eluting alginate microspheres were developed for targeted arterial-infusion chemotherapy. These alginate microspheres were synthesized using a highly efficient microfluidic gelation process. The microspheres included magnetic clusters formed by USPIO nanoparticles to permit MRI and a sustained drug-release profile. The biocompatibility, MR imaging properties and amonafide release kinetics of these microspheres were investigated during in vitro studies. A xenograft rodent model was used to demonstrate the feasibility to deliver these microspheres to liver tumors using hepatic transcatheter intra-arterial infusions and potential to visualize the intra-hepatic delivery of these microspheres to both liver tumor and normal tissues with MRI immediately after infusion. This approach offer the potential for catheter-directed drug delivery to liver tumors for reduced systemic toxicity and superior therapeutic outcomes.
Related Compounds
Related Articles:
2015-04-22
[J. Ethnopharmacol. 164 , 265-72, (2015)]
2015-04-01
[J. Virol. 89(8) , 4636-44, (2015)]
Identification and characterization of epithelial cells derived from human ovarian follicular fluid.
2015-01-01
[Stem Cell Res. Ther. 6 , 13, (2015)]
Matrix stiffening and β1 integrin drive subtype-specific fibroblast accumulation in lung cancer.
2015-01-01
[Mol. Cancer Res. 13(1) , 161-73, (2015)]
The HMGB1 protein sensitizes colon carcinoma cells to cell death triggered by pro-apoptotic agents.
2015-02-01
[Int. J. Oncol. 46(2) , 667-76, (2014)]